Skip to main content
. 2011 Jan 22;13(4):405–412. doi: 10.1016/j.micinf.2011.01.005

Fig. 2.

Fig. 2

Effect of PIDR on the infection with HCVcc. (A) HCVcc was inoculated into Huh7OK1 cells at an MOI of 0.05 in the presence or absence of healthy donor sera (HDS) and PIDR and intracellular viral RNA was measured every 24 h (B) HCVcc was mixed with sera from chronic hepatitis C patients (CHS) or/and PIDR and inoculated into Huh7OK1 cells. (C) HCVcc was pre-mixed with anti-E2 monoclonal antibody (AP-33) and inoculated into Huh7OK1 cells in the presence or absence of PIDR.